The market size in the pharmaceutical tender market is primarily determined by the volume and value of medicines and healthcare products procured through public tenders. These tenders are issued by various government entities, including the Greek National Organization for Healthcare Provision (EOPYY), the Ministry of Health, and regional healthcare authorities. These tenders cover a wide range of pharmaceutical products, from generic medications to specialty drugs and medical devices.

The pharmaceutical tender market's size can vary based on several key factors:
Government Budgets: The market size is closely tied to the public healthcare budget allocated by the Greek government. Fluctuations in healthcare spending can influence the volume and value of tenders.
Disease Prevalence: The prevalence of specific diseases and health conditions can affect the demand for certain pharmaceutical products, impacting the size of tenders related to those products.
Regulatory Changes: Changes in healthcare policies and regulations can lead to adjustments in the tendering process, which may, in turn, impact the market size.
Economic Conditions: Economic stability and growth can have an indirect effect on healthcare budgets and consequently influence the size of pharmaceutical tenders.
Market Competition: The level of competition among pharmaceutical companies in Greece can impact the number of participants in tenders and the final market size.

Pharma14 is now tracking Greece tender results with monthly updates.
Besides Greece tender data, Pharma14 tracks other tender markets such as Spain, Italy, US and many more.

Sample data: Imatinib tender results.